📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation. (2018)

First Author: Gadd AJR

Attributed to: Nanostructured Polymeric Materials for Healthcare funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.ejps.2018.07.048

PubMed Identifier: 30048801

Publication URI: http://europepmc.org/abstract/MED/30048801

Type: Journal Article/Review

Volume: 123

Parent Publication: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

ISSN: 0928-0987